Surfactant and Lung Elastic Recoil: Clarifying the Relationship

Surfactant does not promote elastic recoil. It reduces surface tension, which opposes the collapsing force of elastic recoil, thereby stabilizing alveoli.

Key Concepts

• Elastic recoil: Inward pull of lung tissue (elastin/collagen fibers) + surface tension at air-liquid interface. Tends to collapse alveoli.
• Surfactant (DPPC + proteins): Phospholipid monolayer at air-liquid interface → lowers surface tension (especially at low volumes).
• Laplace's Law: P = 2T/r. Lower surface tension (T) reduces collapsing pressure (P) for a given radius (r).

Functional Outcome

• Prevents alveolar collapse at end-expiration (atelectasis).
• Reduces work of breathing (less pressure needed to inflate).
• Equalizes ventilation: smaller alveoli have lower surface tension → less pressure → less emptying into larger alveoli.

Clinical Relevance

• Neonatal RDS: Surfactant deficiency → high surface tension → diffuse atelectasis.
• ARDS: Surfactant inactivation/degradation contributes to collapse.
• Exogenous surfactant: Replacement therapy improves compliance, oxygenation.

Surfactant and elastic recoil are distinct but interacting forces. Surfactant modulates the surface tension component of recoil, promoting stability, not recoil itself.